Target type: biologicalprocess
The attachment of an adhesion molecule in one cell to a nonidentical adhesion molecule in an adjacent cell. [ISBN:0198506732]
Heterophilic cell-cell adhesion, mediated by plasma membrane cell adhesion molecules (CAMs), is a crucial process in multicellular organisms, enabling cells to interact and form tissues, organs, and maintain tissue integrity. It involves the binding of different types of CAMs on the surfaces of two distinct cells, facilitated by non-identical binding partners. This intricate process is essential for diverse biological functions, including:
* **Development and morphogenesis**: During embryonic development, heterophilic adhesion plays a critical role in cell sorting, migration, and the formation of tissues and organs. Cells expressing specific CAMs adhere to and interact with other cells expressing complementary CAMs, leading to the precise organization and assembly of tissues.
* **Tissue homeostasis**: In adult organisms, heterophilic adhesion is crucial for maintaining tissue integrity and function. It provides the adhesive forces that hold cells together, preventing cell dissociation and maintaining tissue structure. Additionally, it contributes to cell signaling and the regulation of cell behavior.
* **Immune responses**: Heterophilic adhesion plays a role in immune cell interactions and the regulation of immune responses. Immune cells express specific CAMs that enable them to adhere to other cells, such as endothelial cells, leukocytes, and antigen-presenting cells. This adhesion facilitates communication and the activation of immune responses.
* **Wound healing**: During wound healing, heterophilic adhesion is essential for the migration and adhesion of cells to the wound site, promoting tissue repair.
The mechanisms underlying heterophilic cell-cell adhesion via CAMs are complex and involve multiple steps:
1. **CAM expression and localization**: Cells express specific types of CAMs on their plasma membrane, often in a polarized manner. This controlled expression and localization ensure that cells adhere to appropriate partners.
2. **Ligand binding**: CAMs from different cells interact via their extracellular domains. This interaction is typically specific, with CAMs binding to complementary ligands on opposing cells.
3. **Transmembrane signaling**: Binding of CAMs to their ligands triggers intracellular signaling cascades that regulate cell behavior, including adhesion, migration, and gene expression.
4. **Cytoskeletal interactions**: CAMs often interact with the cytoskeleton, providing structural support and facilitating the transmission of forces across cell junctions.
**Examples of heterophilic CAMs**:
* **Cadherins**: A large family of calcium-dependent CAMs that mediate cell-cell adhesion in a variety of tissues. Different cadherins exhibit differential binding affinities, enabling cells to sort and assemble into specific tissues.
* **Immunoglobulin superfamily (IgSF) CAMs**: A diverse family of CAMs that share immunoglobulin-like domains in their extracellular regions. IgSF CAMs are involved in various cellular functions, including adhesion, signaling, and immune responses.
* **Selectins**: A family of carbohydrate-binding CAMs that mediate cell-cell adhesion in various contexts, including leukocyte trafficking and immune responses.
* **Integrins**: Transmembrane receptors that link the extracellular matrix to the cytoskeleton. While integrins primarily mediate cell-matrix adhesion, they can also participate in heterophilic cell-cell interactions.
Heterophilic cell-cell adhesion via CAMs is a highly dynamic process that is regulated by numerous factors, including:
* **Cell type**: Different cell types express different CAMs, determining their adhesive properties and interactions.
* **Extracellular environment**: Factors such as the composition of the extracellular matrix, soluble factors, and mechanical cues can influence CAM expression and function, regulating cell-cell adhesion.
* **Developmental stage**: CAM expression and function can change during development, leading to tissue remodeling and organogenesis.
Understanding the mechanisms of heterophilic cell-cell adhesion is crucial for understanding various biological processes, including development, tissue homeostasis, immune responses, and disease. Dysregulation of heterophilic adhesion can contribute to various diseases, including cancer, autoimmune disorders, and developmental defects. Research efforts continue to unravel the intricate mechanisms of heterophilic adhesion and its role in normal and pathological conditions.'
"
Protein | Definition | Taxonomy |
---|---|---|
L-selectin | An L-selectin that is encoded in the genome of human. [PRO:JAN, UniProtKB:P14151] | Homo sapiens (human) |
P-selectin | A P-selectin that is encoded in the genome of human. [PRO:WCB, UniProtKB:P16109] | Homo sapiens (human) |
CD209 antigen | A CD209 molecule that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q9NNX6] | Homo sapiens (human) |
Galectin-7 | A galectin-7 that is encoded in the genome of human. [PRO:DAN, UniProtKB:P47929] | Homo sapiens (human) |
Integrin alpha-L | An integrin alpha-L that is encoded in the genome of human. [PRO:CNA, UniProtKB:P20701] | Homo sapiens (human) |
Vascular cell adhesion protein 1 | A vascular cell adhesion protein 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P19320] | Homo sapiens (human) |
E-selectin | An E-selectin that is encoded in the genome of human. [PRO:WCB, UniProtKB:P16581] | Homo sapiens (human) |
Integrin alpha-5 | An integrin alpha-5 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P08648] | Homo sapiens (human) |
Intercellular adhesion molecule 1 | An intercellular adhesion molecule 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P05362] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
gallic acid | gallate : A trihydroxybenzoate that is the conjugate base of gallic acid. | trihydroxybenzoic acid | antineoplastic agent; antioxidant; apoptosis inducer; astringent; cyclooxygenase 2 inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; geroprotector; human xenobiotic metabolite; plant metabolite |
bupropion | bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring. Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE. | aromatic ketone; monochlorobenzenes; secondary amino compound | antidepressant; environmental contaminant; xenobiotic |
indole | indole; polycyclic heteroarene | Escherichia coli metabolite | |
probucol | probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood. Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993). | dithioketal; polyphenol | anti-inflammatory drug; anticholesteremic drug; antilipemic drug; antioxidant; cardiovascular drug |
lactose | beta-lactose : The beta-anomer of lactose. lactose : A glycosylglucose disaccharide, found most notably in milk, that consists of D-galactose and D-glucose fragments bonded through a beta-1->4 glycosidic linkage. The glucose fragment can be in either the alpha- or beta-pyranose form, whereas the galactose fragment can only have the beta-pyranose form. Lactose: A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry. | lactose | |
difluorodinitrobenzene sulfone | |||
oxycinchophen | quinolines | ||
1,4-benzodioxan | 1,4-benzodioxan: structure in first source | ||
1-methylindole | 1-methylindole: SKATOLE refers to 3-methylindole; RN given refers to parent cpd; structure methylindole : Any member of the class of indoles carrying one or more methyl substituents. | ||
2,3,4-Trihydroxybenzoic acid | hydroxybenzoic acid | ||
fucose | fucose : Any deoxygalactose that is deoxygenated at the 6-position. Fucose: A six-member ring deoxysugar with the chemical formula C6H12O5. It lacks a hydroxyl group on the carbon at position 6 of the molecule. L-fucopyranose : The pyranose form of L-fucose. | fucopyranose; L-fucose | Escherichia coli metabolite; mouse metabolite |
mannose | mannopyranose : The pyranose form of mannose. | D-aldohexose; D-mannose; mannopyranose | metabolite |
lovastatin | lovastatin : A fatty acid ester that is mevastatin carrying an additional methyl group on the carbobicyclic skeleton. It is used in as an anticholesteremic drug and has been found in fungal species such as Aspergillus terreus and Pleurotus ostreatus (oyster mushroom). Lovastatin: A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver. | delta-lactone; fatty acid ester; hexahydronaphthalenes; polyketide; statin (naturally occurring) | anticholesteremic drug; antineoplastic agent; Aspergillus metabolite; prodrug |
tirofiban | tirofiban : A member of the class of piperidines that is L-tyrosine in which a hydrogen attached to the amino group is replaced by a butylsulfonyl group and in which the hydrogen attached to the phenolic hydroxy group is replaced by a 4-(piperidin-4-yl)butyl group. Tirofiban: Tyrosine analog and PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX antagonist that inhibits PLATELET AGGREGATION and is used in the treatment of ACUTE CORONARY SYNDROME. | L-tyrosine derivative; piperidines; sulfonamide | anticoagulant; fibrin modulating drug; platelet glycoprotein-IIb/IIIa receptor antagonist |
chlorfenethazine | chlorfenethazine: RN given refers to parent cpd; synonym elroquil refers to HCl; structure | phenothiazines | |
methyl alpha-d-galactopyranoside | methyl alpha-D-galactoside : An alpha-D-galactoside having a methyl substituent at the anomeric position. methyl-galactopyranoside: structure in first source | alpha-D-galactoside; methyl D-galactoside; monosaccharide derivative | |
methyl beta-galactoside | methyl beta-D-galactoside : A beta-D-galactopyranoside having a methyl substituent at the anomeric position. methyl beta-galactoside: RN given refers to (beta-D)-isomer methyl galactoside : A methyl glycoside in which the H of the OH group on C-1 of galactose is replaced by a methyl group. | beta-D-galactoside; methyl D-galactoside; monosaccharide derivative | |
arginyl-glycyl-aspartic acid | arginyl-glycyl-aspartic acid: amino acid sequence of basic unit of widespread cellular recognition system | oligopeptide | |
arginyl-glycyl-aspartyl-serine | arginyl-glycyl-aspartyl-serine: corresponds to cell attachment site of fibronectin; located near carboxyl-terminal region of alpha-chain of fibrinogen; inhibits platelet aggregation & fibrinogen binding to activated platelets | ||
thiodigalactoside | thiodigalactoside: RN given refers to beta-D-galactopyranoside (D-Gal)-isomer | ||
methyl lactoside | beta-D-Gal-(1->4)-beta-D-Glc-OMe : A methyl glycoside comprising methyl beta-D-glucoside having an beta-D-galactosyl residue at the 4-position. | disaccharide derivative; methyl glycoside | |
d-arg-gly-asp-trp | arginyl-glycyl-aspartyl-tryptophan: a synthetic RGD-containing peptide | ||
2-bromohippuric acid | |||
l 738167 | L 738167: structure in first source | ||
sulfoquinovosyl dipalmitoyl glyceride | sulfoquinovosyl dipalmitoyl glyceride: P-selectin receptor inhibitor; isolated from the alga Dictyochloris fragrans; structure in first source | ||
cilengitide | Cilengitide: an alphaVbeta3 integrin antagonist that paralyzes cancer cells | oligopeptide | |
l 734217 | L 734217: fibrinogen receptor antagonist; structure given in first source | ||
cucurbitacin r | 23,24-dihydrocucurbitacin D : A 23,24-dihydrocucurbitacin in which a lanostane skeleton is multi-substituted with hydroxy, methyl and oxo substituents, with unsaturation at position 5. cucurbitacin R: from Cayaponia tayuya roots; structure in first source | 23,24-dihydrocucurbitacin; secondary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | |
fixb protein, e coli | alpha-D-mannose : D-Mannopyranose having alpha-configuration at the anomeric centre. alpha-D-mannoside : Any mannoside in which the anomeric centre has alpha-configuration. muscarinic toxin 2: muscarinic agonists from Dendroaspis angusticeps; amino acid sequence given in first source | D-mannopyranose | epitope |
succinobucol | succinobucol: monosuccinic acid ester of probucol; a metabolically stable modification of probucol, an equipotent antioxidant to probucol but is pharmacologically distinct | benzoate ester; phenols | |
n-acetyllactosamine | N-acetyllactosamine : A beta-D-galactopyranosyl-(1->4)-N-acetyl-D-glucosamine having beta-configuration at the reducing end anomeric centre. N-acetyllactosamine: RN given refers to D-isomer | beta-D-Galp-(1->4)-D-GlcpNAc | |
benzotript | benzotript: anti-gastrinic; active group is amide; structure | ||
arginyl-glycyl-aspartyl-phenylalanine | |||
cucurbitacin d | cucurbitacin D : A cucurbitacin in which a lanostane skeleton is multi-substituted with hydroxy, methyl and oxo substituents, with unsaturation at positions 5 and 23. cucurbitacin D: toxic constituent in edible gourd; see also records for cucurbitacins & specific cucurbitacins | cucurbitacin; secondary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | |
nsc 106399 | cucurbitacin E : A cucurbitacin in which a lanostane skeleton is multi-substituted with hydroxy, methyl and oxo substituents, with unsaturation at positions 1, 5 and 23. cucurbitacin E: RN refers to (9beta,10alpha,16alpha,23E)-isomer; structure given in first source | cucurbitacin; tertiary alpha-hydroxy ketone | |
cucurbitacin i | cucurbitacin I : A cucurbitacin that is 9,10,14-trimethyl-4,9-cyclo-9,10-secocholesta-2,5,23-triene substituted by hydroxy groups at positions 2, 16, 20 and 25 and oxo groups at positions 1, 11 and 22. cucurbitacin I: toxic constituent in edible gourd; see also records for cucurbitacins & specific cucurbitacins | cucurbitacin; tertiary alpha-hydroxy ketone | antineoplastic agent; plant metabolite |
pd 144795 | |||
birt 377 | |||
bimosiamose | bimosiamose: a selectin inhibitor | ||
4-[(4-methylphenyl)thio]-2-thieno[2,3-c]pyridinecarboxamide | aryl sulfide | ||
a 286982 | A 286982: inhibits the interaction between leukocyte function-associated antigen-1 and intracellular adhesion molecule-1; structure in first source | ||
cyclic(arg-gly-asp-d-phe-val) | |||
mk-0429 | |||
bio 1211 | BIO 1211: integrin alpha4beta1 inhibitor; structure in first source | ||
sar 1118 | lifitegrast : An N-acyl-L-alpha-amino acid obtained by formal condensation of the carboxy group of N-[2-(1-benzofuran-6-carbonyl)]-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid with the amino group of 3-(methanesulfonyl)-L-phenylalanine. Used for treatment of keratoconjunctivitis sicca (dry eye syndrome). lifitegrast: An LFA-1 (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1) antagonist that is used in the treatment of DRY EYE SYNDROMES. | 1-benzofurans; isoquinolines; L-phenylalanine derivative; N-acyl-L-alpha-amino acid; sulfone | anti-inflammatory drug; lymphocyte function-associated antigen-1 antagonist |
psi 697 | 2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo(H)quinoline-4-carboxylic acid: inhibitor of P selectin that decreases vein wall injury in a rat stenosis model of venous thrombosis | ||
galactocerebroside | galactocerebroside: a NITROGEN containing sphingolipid |